M11.16

Clinical Causes: Genetic factors: Inherited mutations that affect cartilage metabolism and calcium regulation. Age-related changes: Increased likelihood of crystal deposition with advancing age. Underlying metabolic disorders: Conditions such as hyperparathyroidism, hemochromatosis, and hypophosphatasia can predispose individuals to CPPD deposition. Previous joint trauma or surgery: Can alter joint cartilage and promote crystal formation. Other joint diseases: Osteoarthritis and other degenerative joint conditions may coexist with or predispose to chondrocalcinosis.

Key Symptoms: Joint pain and tenderness in the affected knee. Swelling and inflammation around the joint. Stiffness, especially after periods of inactivity or rest. Reduced range of motion in the knee. Possible episodes of acute flare-ups resembling gout, with sudden and severe pain. Asymptomatic cases: Some individuals may have incidental findings of calcium deposits without symptoms.

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. X-rays are key in identifying calcification in the cartilage of the knee, characteristic of chondrocalcinosis. Arthrocentesis, or joint fluid aspiration, may reveal CPPD crystals under polarized light microscopy. Blood tests may check for metabolic conditions associated with CPPD, such as calcium and phosphate levels, or markers of other systemic diseases. A detailed medical and family history helps determine the hereditary nature of the condition.

Treatment Protocols: Management focuses on alleviating symptoms and preventing joint damage. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - Colchicine, sometimes used during acute attacks or for prophylaxis. - Corticosteroid injections into the affected joint for severe inflammation. - Physical therapy to improve joint function and strength. - Lifestyle modifications, including weight management and joint protection strategies. - Addressing underlying metabolic or systemic conditions that might contribute to crystal formation. Surgical options such as joint replacement may be considered in advanced cases with significant joint damage. Coordination with healthcare professionals can help tailor a management plan suited to individual needs.